Cookie Consent by Interview with Dr. R. Roitman – Peptiline

Dr. Med. R. Roitman

Dr. Med. R. Roitman spoke about WHO Symposium

In Geneva, the international symposium on human longevity has ended. Representative of Ideal Pharma Peptide GmbH - Dr. Ing. Med. R.

Roitman has shared his impressions of the event.

According to Dr. Med. Roitman, it is very good that the issues of human longevity are not just doctors and scientists, but also World Health Organization (WHO). The lifespan of modern humans has increased compared to the previous centuries. Nonetheless, such events as the symposium are significant and extremely important.

Dr. Med. Roitman was particularly impressed by Professor T. Lezhava's presentation on epigenetics, as well as Professor V. Khavinson's lecture on his development of short peptides. Dr. Med. Roitman also highlighted the prospect of short peptides and peptide complexes that have attracted scientists from around the world over the past 40 years.

Already, the peptides are used in many areas and products:

medicine, cosmetics, sports nutrition, dietary supplements. Dr. Med. Roitman expressed the hope that in the near future, thanks to the peptides, scientists will be able to diagnose and treat the diseases at the earliest stages at the cellular level.